PATENT CLAIM ANALYSIS

Application Number: 15758866
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "300000"]

Abstract:
The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.

Claim (Index 6):
The compound of  claim 1 , wherein:\n R 4  and R 5  are independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, C 1-2  alkyl, C 1-2  halogenated alkyl, C 1-2  alkoxy or C 1-2  alkylthio.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 90.0
- Lexical Diversity: 1.40476
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12935478', '13509442', '13266976', '12356940', '14719075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8296569999277166
- 35 USC 102 Novelty (BERT): 0.5341837426463039
- Combined Prediction Score: 0.8001096741995753
- Mean Citation Score: 334.048602
- Max Citation Score: 375.2025
- Similarity Product: 308.6490262971818

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test